(WSJ) – “If you’re carrying 15-20 extra pounds,” it says, “medications like Wegovy can help jumpstart your progress.” For obesity doctors and researchers, this kind of messaging is problematic. The blockbuster drugs—known as GLP-1s—are increasingly marketed as lifestyle fixes to … Read More
https://bioethics.com/archives/101358